SCHEMBL26633720

SCHEMBL26633720

COc1ccc(CNC(=O)NC2CC3(C2)CC(C(=O)N2CCCc4ccccc42)C3)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.54
▸ THRB P10828 1/20 0.54
▸ PDE4B Q07343 1/20 0.52
▸ PDE4D Q08499 1/20 0.52
▸ TSHR P16473 3/20 0.52
▸ MAPT P10636 5/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ TP53 P04637 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ GAA P10253 4/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ MAPK1 P28482 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30288091 1.00 ALDH1A1 (0.54) ALDH1A1THRBPDE4BPDE4DTSHR
SCHEMBL26764371 1.00 ALDH1A1 (0.54) ALDH1A1THRBPDE4BPDE4DTSHR
SCHEMBL26633743 0.95 RAB9A (0.53) ALDH1A1THRBPDE4BPDE4DTSHR
SCHEMBL24011335 0.89 RAB9A (0.57) ALDH1A1THRBPDE4BPDE4DTSHR
SCHEMBL24011331 0.89 RAB9A (0.57) ALDH1A1THRBPDE4BPDE4DTSHR
SCHEMBL24011484 0.89 RAB9A (0.57) ALDH1A1THRBPDE4BPDE4DTSHR
SCHEMBL30288092 0.89 MCHR1 (0.48) ALDH1A1THRBMAPTRAB9ASMN1; SMN2
SCHEMBL30288081 0.89 LMNA (0.49) ALDH1A1MAPTRAB9ASMN1; SMN2NPC1
SCHEMBL26633875 0.89 MCHR1 (0.48) ALDH1A1THRBMAPTRAB9ASMN1; SMN2
SCHEMBL26633772 0.89 RAB9A (0.48) ALDH1A1THRBPDE4BPDE4DMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT ALDH1A1 982/4885THRB 1014/4885PDE4B 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback